Effect of chronic morphine administration on circulating T cell population dynamics in rhesus macaques

Journal of Neuroimmunology

Volumn 265, Issue 1-2, 2013, Pages 43-50

  Cornwell, William D ^a   Lewis, Mark G ^b   Fan, Xiaoxuan ^a   Rappaport, Jay ^a   Rogers, Thomas J ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BIOQUAL INC   (United States)

Author keywords

7 integrin; FoxP3; IL 17A; Morphine; Th17 cells; Treg cells

Indexed keywords

BETA7 INTEGRIN; CD161 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR6; MORPHINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVITY; CHRONIC DRUG ADMINISTRATION; IMMUNE RESPONSE; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH17 CELL;

Β7 INTEGRIN; FOXP3; IL-17A; MORPHINE; TH17 CELLS; TREG CELLS;

ANIMALS; ANTIGENS, CD; CELL MOVEMENT; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; INTERFERON-GAMMA; INTERLEUKIN-17; MACACA MULATTA; MORPHINE; NARCOTICS; RECEPTORS, CCR5; RECEPTORS, CXCR4; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES; TIME FACTORS;

EID: 84888345912     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2013.09.013     Document Type: Article

References (74)

1. Annunziato F., Cosmi L., Santarlasci V., Maggi L., Liotta F., Mazzinghi B., Parente E., Fili L., Ferri S., Frosali F., Giudici F., Romagnani P., Parronchi P., Tonelli F., Maggi E., Romagnani S. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 2007, 204:1849-1861.
2. Annunziato F., Cosmi L., Liotta F., Maggi E., Romagnani S. Defining the human T helper 17 cell phenotype. Trends Immunol. 2012, 33:505-512.
3. Arthos J., Cicala C., Martinelli E., Macleod K., Van R.D., Wei D., Xiao Z., Veenstra T.D., Conrad T.P., Lempicki R.A., McLaughlin S., Pascuccio M., Gopaul R., McNally J., Cruz C.C., Censoplano N., Chung E., Reitano K.N., Kottilil S., Goode D.J., Fauci A.S. HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells. Nat. Immunol. 2008, 9:301-309.
4. Azarang A., Mahmoodi M., Rajabalian S., Shekari M.A., Nosratabadi J., Rezaei N. T-helper 1 and 2 serum cytokine assay in chronic opioid addicts. Eur. Cytokine Netw. 2007, 18:210-214.
5. Bezouska K., Yuen C.T., O'Brien J., Childs R.A., Chai W., Lawson A.M., Drbal K., Fiserova A., Pospisil M., Feizi T. Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity. Nature 1994, 372:150-157. [Erratum appears in Nature 1996 Apr 11; 380 (6574): 559].
6. Billerbeck E., Kang Y.H., Walker L., Lockstone H., Grafmueller S., Fleming V., Flint J., Willberg C.B., Bengsch B., Seigel B., Ramamurthy N., Zitzmann N., Barnes E.J., Thevanayagam J., Bhagwanani A., Leslie A., Oo Y.H., Kollnberger S., Bowness P., Drognitz O., Adams D.H., Blum H.E., Thimme R., Klenerman P. Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:3006-3011.
7. Brand J.M., Frohn C., Luhm J., Kirchner H., Schmucker P. Early alterations in the number of circulating lymphocyte subpopulations and enhanced proinflammatory immune response during opioid-based general anesthesia. Shock 2003, 20:213-217.
8. Bromley S.K., Burack W.R., Johnson K.G., Somersalo K., Sims T.N., Sumen C., Davis M.M., Shaw A.S., Allen P.M., Dustin M.L. The immunological synapse. Annu. Rev. Immunol. 2001, 19:375-396.
9. Carr D.J., France C.P. Immune alterations in morphine-treated rhesus monkeys. J. Pharmacol. Exp. Ther. 1993, 267:9-15.
10. Cicala C., Martinelli E., McNally J.P., Goode D.J., Gopaul R., Hiatt J., Jelicic K., Kottilil S., Macleod K., O'Shea A., Patel N., Van R.D., Wei D., Pascuccio M., Yi L., McKinnon L., Izulla P., Kimani J., Kaul R., Fauci A.S., Arthos J. The integrin alpha4beta7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:20877-20882.
11. Cosmi L., De P.R., Santarlasci V., Maggi L., Capone M., Frosali F., Rodolico G., Querci V., Abbate G., Angeli R., Berrino L., Fambrini M., Caproni M., Tonelli F., Lazzeri E., Parronchi P., Liotta F., Maggi E., Romagnani S., Annunziato F. Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. J. Exp. Med. 2008, 205:1903-1916.
12. Curtis M.M., Way S.S., Wilson C.B. IL-23 promotes the production of IL-17 by antigen-specific CD8 T cells in the absence of IL-12 and type-I interferons. J. Immunol. 2009, 183:381-387.
13. Donahoe R.M., Bueso-Ramos C., Donahoe F., Madden J.J., Falek, Nicholson J.K., Bokos P. Mechanistic implications of the findings that opiates and other drugs of abuse moderate T-cell surface receptors and antigenic markers. Ann. N. Y. Acad. Sci. 1987, 496:711-721.
14. Donahoe R.M., Byrd L.D., McClure H.M., Brantley M., Wenzel D., Ansari A.A., Marsteller F. Effects of morphine on T-cell recirculation in rhesus monkeys. Adv. Exp. Med. Biol. 2001, 493:89-101.
15. Dong C. Differentiation and function of pro-inflammatory Th17 cells. Microbes Infect. 2009, 11:584-588.
16. Eisenstein T.K., Meissler J.J., Rogers T.J., Geller E.B., Adler M.W. Mouse strain differences in immunosuppression by opioids in vitro. J. Pharmacol. Exp. Ther. 1995, 275:1484-1489.
17. El H.A., Khaitan A., Kozhaya L., Manel N., Daskalakis D., Borkowsky W., Valentine F., Littman D.R., Unutmaz D. Susceptibility of human Th17 cells to human immunodeficiency virus and their perturbation during infection. J. Infect. Dis. 2010, 201:843-854.
18. Fields M.L., Hondowicz B.D., Metzgar M.H., Nish S.A., Wharton G.N., Picca C.C., Caton A.J., Erikson J. CD4+CD25+ regulatory T cells inhibit the maturation but not the initiation of an autoantibody response. J. Immunol. 2005, 175:4255-4264.
19. Gao M., Sun J., Jin W., Qian Y. Morphine, but not ketamine, decreases the ratio of Th1/Th2 in CD4- positive cells through T-bet and GATA3. Inflammation 2012, 35:1069-1077.
20. Garcia-Hernandez M.L., Hamada H., Reome J.B., Misra S.K., Tighe M.P., Dutton R.W. Adoptive transfer of tumor-specific Tc17 effector T cells controls the growth of B16 melanoma in mice. J. Immunol. 2010, 184:4215-4227.
21. Ghiringhelli F., Menard C., Terme M., Flament C., Taieb J., Chaput N., Puig P.E., Novault S., Escudier B., Vivier E., Lecesne A., Robert C., Blay J.Y., Bernard J., Caillat-Zucman S., Freitas A., Tursz T., Wagner-Ballon O., Capron C., Vainchencker W., Martin F., Zitvogel L. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. J. Exp. Med. 2005, 202:1075-1085.
22. Gosselin A., Monteiro P., Chomont N., Diaz-Griffero F., Said E.A., Fonseca S., Wacleche V., El-Far M., Boulassel M.R., Routy J.P., Sekaly R.P., Ancuta P. Peripheral blood CCR4+CCR6+ and CXCR3+CCR6+CD4+ T cells are highly permissive to HIV-1 infection. J. Immunol. 2010, 184:1604-1616.
23. Govitrapong P., Suttitum T., Kotchabhakdi N., Uneklabh T. Alterations of immune functions in heroin addicts and heroin withdrawal subjects. J. Pharmacol. Exp. Ther. 1998, 286:883-889.
24. Green E.A., Gorelik L., McGregor C.M., Tran E.H., Flavell R.A. CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:10878-10883.
25. Guan L., Townsend R., Eisenstein T.K., Adler M.W., Rogers T.J. Both T cells and macrophages are targets of kappa-opioid-induced immunosuppression. Brain Behav. Immun. 1994, 8:229-240.
26. Guillot-Delost M., Le G.S., Mesel-Lemoine M., Cherai M., Baillou C., Simon A., Levy Y., Weiss L., Louafi S., Chaput N., Berrehar F., Kerbrat S., Klatzmann D., Lemoine F.M. Human CD90 identifies Th17/Tc17 T cell subsets that are depleted in HIV-infected patients. J. Immunol. 2012, 188:981-991.
27. Hamada H., Garcia-Hernandez M.L., Reome J.B., Misra S.K., Strutt T.M., McKinstry K.K., Cooper A.M., Swain S.L., Dutton R.W. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J. Immunol. 2009, 182:3469-3481.
28. Happel C., Steele A.D., Finley M.J., Kutzler M.A., Rogers T.J. DAMGO-induced expression of chemokines and chemokine receptors: the role of TGF-{beta}1. J. Leukoc. Biol. 2008, 83:956-963.
29. Hashiguchi S., Morisaki H., Kotake Y., Takeda J. Effects of morphine and its metabolites on immune function in advanced cancer patients. J. Clin. Anesth. 2005, 17:575-580.
30. Hu S., Chao C.C., Hegg C.C., Thayer S., Peterson P.K. Morphine inhibits human microglial cell production of, and migration towards, RANTES. J. Psychopharmacol. 2000, 14:238-243.
31. Huber M., Heink S., Grothe H., Guralnik A., Reinhard K., Elflein K., Hunig T., Mittrucker H.W., Brustle A., Kamradt T., Lohoff M. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity. Eur. J. Immunol. 2009, 39:1716-1725.
32. Huter E.N., Stummvoll G.H., DiPaolo R.J., Glass D.D., Shevach E.M. Cutting edge: antigen-specific TGF beta-induced regulatory T cells suppress Th17-mediated autoimmune disease. J. Immunol. 2008, 181:8209-8213.
33. Ito T., Hanabuchi S., Wang Y.H., Park W.R., Arima K., Bover L., Qin F.X., Gilliet M., Liu Y.J. Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity 2008, 28:870-880.
34. Kleinschek M.A., Boniface K., Sadekova S., Grein J., Murphy E.E., Turner S.P., Raskin L., Desai B., Faubion W.A., de Waal M.R., Pierce R.H., McClanahan T., Kastelein R.A. Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. J. Exp. Med. 2009, 206:525-534.
35. Kuang D.M., Peng C., Zhao Q., Wu Y., Zhu L.Y., Wang J., Yin X.Y., Li L., Zheng L. Tumor-activated monocytes promote expansion of IL-17-producing CD8+ T cells in hepatocellular carcinoma patients. J. Immunol. 2010, 185:1544-1549.
36. Lanier L.L., Chang C., Phillips J.H. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J. Immunol. 1994, 153:2417-2428.
37. Li M.O., Wan Y.Y., Sanjabi S., Robertson A.K., Flavell R.A. Transforming growth factor-beta regulation of immune responses. Annu. Rev. Immunol. 2006, 24:99-146.
38. Lim H.W., Hillsamer P., Banham A.H., Kim C.H. Cutting edge: direct suppression of B cells by CD4+CD25+ regulatory T cells. J. Immunol. 2005, 175:4180-4183.
39. Linner K.M., Quist H.E., Sharp B.M. Expression and function of proenkephalin A messenger ribonucleic acid in murine fetal thymocytes. Endocrinology 1996, 137:857-863.
40. Liu G., Ma H., Qiu L., Li L., Cao Y., Ma J., Zhao Y. Phenotypic and functional switch of macrophages induced by regulatory CD4+CD25+ T cells in mice. Immunol. Cell Biol. 2011, 89:130-142.
41. Lysle D.T., Coussons M.E., Watts V.J., Bennett E.H., Dykstra L.A. Morphine-induced modulation of immune status: evidence for opioid receptor mediation and compartment specificity. Adv. Exp. Med. Biol. 1993, 335:53-59.
42. Ma J., Wang J., Wan J., Charboneau R., Chang Y., Barke R.A., Roy S. Morphine disrupts interleukin-23 (IL-23)/IL-17-mediated pulmonary mucosal host defense against Streptococcus pneumoniae infection. Infect. Immun. 2010, 78:830-837.
43. Mahajan S.D., Schwartz S.A., Aalinkeel R., Chawda R.P., Sykes D.E., Nair M.P. Morphine modulates chemokine gene regulation in normal human astrocytes. Clin. Immunol. 2005, 115:323-332.
44. McCarthy L.E., Rogers T.J. Alteration of early T cell development by opioid and superantigen stimulation. Adv. Exp. Med. Biol. 2001, 493:163-167.
45. McCarthy L., Szabo I., Nitsche J.F., Pintar J.E., Rogers T.J. Expression of functional mu-opioid receptors during T cell development. J. Neuroimmunol. 2001, 114:173-180.
46. Nigam P., Kwa S., Velu V., Amara R.R. Loss of IL-17-producing CD8 T cells during late chronic stage of pathogenic simian immunodeficiency virus infection. J. Immunol. 2011, 186:745-753.
47. Novick D.M., Ochshorn M., Ghali V., Croxson T.S., Mercer W.D., Chiorazzi N., Kreek M.J. Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients. J. Pharmacol. Exp. Ther. 1989, 250:606-610.
48. Ogata K., Nakamura K., Yokose N., Tamura H., Tachibana M., Taniguchi O., Iwakiri R., Hayashi T., Sakamaki H., Murai Y., Tohyama K., Tomoyasu S., Nonaka Y., Mori M., Dan K., Yoshida Y. Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome. Blood 2002, 100:3887-3896.
49. Peterson P.K., Sharp B., Gekker G., Brummitt Keane W.F. Opioid-mediated suppression of interferon-gamma production by cultured peripheral blood mononuclear cells. J. Clin. Invest. 1987, 80:824-831.
50. Piccirillo C.A., Shevach E.M., Piccirillo C.A., Shevach E.M. Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J. Immunol. 2001, 167:1137-1140.
51. Piguet V., Sattentau Q., Piguet V., Sattentau Q. Dangerous liaisons at the virological synapse. J. Clin. Invest. 2004, 114:605-610.
52. Prendergast A., Prado J.G., Kang Y.H., Chen F., Riddell L.A., Luzzi G., Goulder P., Klenerman P. HIV-1 infection is characterized by profound depletion of CD161+ Th17 cells and gradual decline in regulatory T cells. AIDS 2010, 24:491-502.
53. Roberts A.B. TGF-beta signaling from receptors to the nucleus. Microbes Infect. 1999, 1:1265-1273.
54. Rock R.B., Hu S., Sheng W.S., Peterson P.K. Morphine stimulates CCL2 production by human neurons. J. Neuroinflammation 2006, 3:32.
55. Rojavin M., Szabo I., Bussiere J.L., Rogers T.J., Adler M.W., Eisenstein T.K. Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages. Life Sci. 1993, 53:997-1006.
56. Roy S., Balasubramanian S., Sumandeep S., Charboneau R., Wang J., Melnyk D., Beilman G.J., Vatassery R., Barke R.A. Morphine directs T cells toward T(H2) differentiation. Surgery 2001, 130:304-309.
57. Sakaguchi S., Yamaguchi T., Nomura T., Ono M. Regulatory T cells and immune tolerance. Cell 2008, 133:775-787.
58. Sakaguchi S., Miyara M., Costantino C.M., Hafler D.A. FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol. 2010, 10:490-500.
59. Steele A.D., Henderson E.E., Rogers T.J. Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication. Virology 2003, 309:99-107.
60. Stummvoll G.H., DiPaolo R.J., Huter E.N., Davidson T.S., Glass D., Ward J.M., Shevach E.M. Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells. J. Immunol. 2008, 181:1908-1916.
61. Szabo I., Rojavin M., Bussiere J.L., Eisenstein T.K., Adler M.W., Rogers T.J. Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids. J. Pharmacol. Exp. Ther. 1993, 267:703-706.
62. Taub D.D., Eisenstein T.K., Geller E.B., Adler M.W., Rogers T.J. Immunomodulatory activity of mu- and kappa-selective opioid agonists. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:360-364.
63. Tiemessen M.M., Jagger A.L., Evans H.G., van Herwijnen M.J., John S., Taams L.S. CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:19446-19451.
64. Van Y.H., Lee W.H., Ortiz S., Lee M.H., Qin H.J., Liu C.P. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells. Diabetes 2009, 58:146-155.
65. Volk T., Schenk M., Voigt K., Tohtz S., Putzier M., Kox W.J. Postoperative epidural anesthesia preserves lymphocyte, but not monocyte, immune function after major spine surgery. Anesth. Analg. 2004, 98:1086-1092.
66. Wang J., Charboneau R., Balasubramanian S., Barke R.A., Loh H.H., Roy S. Morphine modulates lymph node-derived T lymphocyte function: role of caspase-3, -8, and nitric oxide. J. Leuk. Biol. 2001, 70:527-536.
67. Wang J., Barke R.A., Charboneau R., Roy S. Morphine impairs host innate immune response and increases susceptibility to Streptococcus pneumoniae lung infection. J. Immunol. 2005, 174:426-434.
68. Wang J., Ma J., Charboneau R., Barke R., Roy S. Morphine inhibits murine dendritic cell IL-23 production by modulating Toll-like receptor 2 and Nod2 signaling. J. Biol. Chem. 2011, 286:10225-10232.
69. Weber R.J., Pert A. The periaqueductal gray matter mediates opiate-induced immunosuppression. Science 1989, 245:188-190.
70. Weed M.R., Carruth L.M., Adams R.J., Ator N.A., Hienz R.D. Morphine withdrawal dramatically reduces lymphocytes in morphine-dependent macaques. J. Neuroimmune Pharmacol. 2006, 1:250-259.
71. Wetzel M.A., Steele A.D., Eisenstein T.K., Adler M.W., Henderson E.E., Rogers T.J. Mu-opioid induction of monocyte chemoattractant protein-1, RANTES, and IFN-gamma-inducible protein-10 expression in human peripheral blood mononuclear cells. J. Immunol. 2000, 165:6519-6524.
72. Yeh N., Glosson N.L., Wang N., Guindon L., McKinley C., Hamada H., Li Q., Dutton R.W., Shrikant P., Zhou B., Brutkiewicz R.R., Blum J.S., Kaplan M.H. Tc17 cells are capable of mediating immunity to vaccinia virus by acquisition of a cytotoxic phenotype. J. Immunol. 2010, 185:2089-2098.
73. Yen H.R., Harris T.J., Wada S., Grosso J.F., Getnet D., Goldberg M.V., Liang K.L., Bruno T.C., Pyle K.J., Chan S.L., Anders R.A., Trimble C.L., Adler A.J., Lin T.Y., Pardoll D.M., Huang C.T., Drake C.G. Tc17 CD8 T cells: functional plasticity and subset diversity. J. Immunol. 2009, 183:7161-7168.
74. Yokoyama M., Itano Y., Katayama H., Morimatsu H., Takeda Y., Takahashi T., Nagano O., Morita K. The effects of continuous epidural anesthesia and analgesia on stress response and immune function in patients undergoing radical esophagectomy. Anesth. Analg. 2005, 101:1521-1527.